Ariel Investments Re-adds Bio-Rad Laboratories to Ariel Focus Fund

In its Q1 2026 investor letter, Ariel Investments re-added Bio-Rad Laboratories (BIO) due to strong margins and market leadership. The Ariel Focus Fund outperformed the S&P 500 by gaining 7.30% amid a volatile market environment driven by geopolitical tensions.

By Attiya Zainib Tue, May 5, 2026 at 7:14 PM GMT+3 3 min read · Yahoo Finance · May 5, 2026, 16:14 UTC

Ariel Investments Re-adds Bio-Rad Laboratories to Ariel Focus Fund

Tickers: $BIO

Topics: market performance portfolio management stock picks

Read the full article at Yahoo Finance

More World news

California Supreme Court to Rule on Insurance Overcharge Liability Under Proposition 103 PR Newswire · November 12, 2026, 18:44 UTC
Federal Court Orders Veterans Guardian to Pay Treble Damages to Disabled Veteran Class PR Newswire · November 12, 2026, 18:41 UTC
AIRO Group Holdings Reaffirms 2026 Revenue Growth Guidance Amid $200 Million Drone Backlog Seeking Alpha · November 12, 2026, 18:40 UTC
Nvidia CEO Jensen Huang Resigns Amid Personal Scandal, Raising Uncertainty for Open Source AI Strategy TechCrunch · November 12, 2026, 18:39 UTC
Vor Bio and RemeGen Expand Collaboration for Autoimmune Disease Therapy Seeking Alpha · November 12, 2026, 18:35 UTC
EnterpriseDB Hires CMRD Engineering Team to Strengthen Sovereign AI Governance PR Newswire · November 12, 2026, 18:36 UTC
Alliant Credit Union Executive Meredith Ritchie Named 2027 Chicago Titan 100 Honoree PR Newswire · November 12, 2026, 18:36 UTC
Fed's Schmid Argues Construction Productivity is Key to Housing Affordability Over Interest Rate Cuts Seeking Alpha · November 12, 2026, 18:33 UTC
PROG Holdings Reports 59% GMV Growth and Announces $100 Million Share Repurchase Program Motley Fool · November 12, 2026, 18:30 UTC
Corteva Shares Plunge Over Q3 Earnings Miss and Pricing Pressures Motley Fool · November 12, 2026, 18:31 UTC